Have a baseline BMI (prior to any weight-loss treatment) of 30 or 25 with one or more previously diagnosed conditions: Controlled Type II Diabetes, Sleep Apnea, High Cholesterol, High Triglycerides, Prediabetes, High Blood Pressure, Heart disease, Osteoarthritis, Polycystic Ovarian Syndrome (PCOS), Non-alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease, Gastroesophageal Reflux Disease (GERD), Depression, Anxiety, Weight-Related Psychosocial Distress, Stroke, Coronary Artery Disease, Metabolic Syndrome, Insulin Resistance, Body Pain, Infertility, Hypothyroidism, Sexual Dysfunction
Symptoms like seizures, delirium tremens, depression, heart attacks, and strokes need immediate medical attention and intervention to prevent complications
Patients with slower metabolic rates, higher body weight, or certain liver or kidney variations may retain semaglutide slightly longer than others
The net effect varies individually and often shifts throughout the protocol
gene, PCSK1 ) is expressed in L cells to produce GLP-1, while prohormone convertase 2 (protein, PC2
Rotating injection sites between abdomen, stomach , thigh , and upper arm minimizes this